In critically ill patients some quantification of cardiac performance is frequently sought in order to assess need for and response to treatment. The postulate was advanced by Swan et al. 1 that a transvenous balloon-tipped catheter wedged into a branch of the pulmonary artery would be able to measure the pulmonary capillary back pressure and therefore give some indication of left heart performance. This technique and its adaptations have received such widespread acceptance that some consider its use "imperative", "essential" and a sine qua non of good practice in the management of those critically ill patients in whom cardiovascular status is uncertain or labile. 2 -6 However, this enthusiasm for invasive haemodynamic monitoring should be tempered by the knowledge that all forms of invasive monitoring are subject to the complications of invasion and that the incidence of these complications is proportional to the degree and duration of invasion. Further, the value and clinical usefulness of the information gained is reduced by a variety of hidden factors which frequently are undetected or unappreciated.
Less than four years after pulmonary artery catheters were introduced into clinical practice, Pace 7 collected 104 published reports of complications of their use. A similar and even larger experience has occurred since. Reputable units have undertaken prospective surveys8-11 which report some complication in 10070, serious complications in 2% and a mortality directly related to these catheters up to 0.4%. This incidence of complications is higher than that encountered in any other investigative or diagnostic aid employed in clinical medicine. Further these complications are increasingly encountered the longer the catheters are left in situ. Approximately 20% of patients have catheter-related sepsis after only 72 hours -a period considerably shorter than the duration of some critical illnesses.
Major complications included vascular 12 and pulmonary13 perforations, thrombosis,14 mechanical difficulties,15,16 sepsis 9 and faulty readings. 17 . 18 The last has not been fully examined but is no doubt more widespread than appreciated. Any system in which there is acceptance of signals generated some 60 cm from the point of percutaneous introduction and in which there is presumption of physical and anatomical normality between the pulmonary capillary and the left ventricle must be liable to a wide range of variables. All of these potential errors and physical complications represent highly undesirable consequences in critically ill patients.
Because sepsis is becoming recognised as the major cause of death in the critically ill it appears illogical that intensivists should advocate the frequent use of an investigation which encourages its development. A higher incidence of sepsis-related complications can be anticipated if invasive techniques are employed. Critical illnesses, particularly those involving systemic arterial hypotension, are associated with immune suppression 19 and subsequent sepsis. 20 The presence of intravascular foreign bodies increases the likelihood of sepsis in Anaesthesia and Intensive Care, Vol. 11, No. I, February, 1983 immune suppressed states. 21 The increase in sepsis-related deaths in intensive care units may well be attributable in part, at least, to the increased use of invasive monitoring as well as invasive treatment. 22 Perhaps most significantly also there is no evidence that invasive haemodynamic monitoring has resulted in improved outcome in any critical illness. There is some evidence that it does not change outcome. In a pertinent report 23 the expected outcome from severe heart failure after myocardial infarction was uninfluenced by the use of invasive haemodynamic monitoring or vasodilator treatment. Perhaps this result is derived from equation of gains and losses as a result of invasion.
Because invasive haemodynamic monitoring is an attractive and sophisticated technology its widespread adoption has resulted in failure to develop just as clinically useful 24 and accurate 25 non-invasive methods of estimating cardiac performance. Systolic time intervals 26 The remarkable growth of interest in and complexity of pain clinics demands that their present role be critically examined. There is no doubt that real progress has been made in the treatment of intractable pain during the past two decades. However, it is regrettable that much of the observed growth should be deplored as it has lacked control or direction and has been too often superficial in substance and without the necessary medical or scientific discipline to achieve lasting acceptance.
To provide a background one should start with some generalisations about pain management in medical practice.
Every physician has to treat patients whose main complaint is pain. This is a part of his normal professional role and naturally he would not consider this function under normal circumstances to be the prerogative of any special discipline. Furthermore, his experience in the management of pain would surely exceed that of the pain therapist. It is well to remember that for all patients who complain of pain it is the family physician who has the major task of establishing a diagnosis and commencing treatment. Should the pain become chronic or the condition life-threatening he will be obliged to supervise long-term treatment and offer appropriate advice and support to both patient and family. Such continuing care by the family physician is the cornerstone of treatment of patients in the terminal stages of cancer where pain is commonly a prominent symptom. Failure to achieve a good standard of pain management at this primary level is an admission of the failure of our medical education rather than an argument for the proliferation of pain clinics. Certainly in a number of cases the general practitioner will, at some stage, require specialist help with diagnosis and treatment. The ensuing consultation will usually bring in its train the necessary investigations and treatment which will satisfactorily resolve the patient's problem.
However, on occasions the pain will persist to become intractable and seemingly unmanageable. This situation usually indicates a complex physical and psychological disease pattern which may have been part of the initial problem or it may have been exacerbated by earlier errors in diagnosis and treatment. It is at this stage that the patient may be referred to a higher specialist level, such as the pain clinic, where a variety of consultants can be mobilised to provide a wider spectrum of understanding and treatment. It is my view that the role of the pain service, whether it be mono-or multidisciplinary, should be confined to the management of these relatively rare. and complex chronic problems.
At the present time the indications are that this view is either not widely held or at least not acted upon since we have seen during the past decade the treatment of chronic pain, in pain clinics or by 'pain therapists', become a major growth industry within the health delivery system. This has occurred seemingly with the connivance of uncritical physicians and without any cost benefit analysis. 1 The more important reasons for this growth include: 1. unreal expectations within the community based on the seductive premise that in this modern
